Edition:
United Kingdom

MGC Diagnostics Corp (MGCD.OQ)

MGCD.OQ on NASDAQ Stock Exchange Capital Market

11.01USD
15 Dec 2017
Change (% chg)

$0.01 (+0.09%)
Prev Close
$11.00
Open
$10.99
Day's High
$11.02
Day's Low
$10.99
Volume
17,393
Avg. Vol
8,364
52-wk High
$11.20
52-wk Low
$6.24

Chart for

About

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting... (more)
No analyst recommendations are available for .

Overall

Beta: -0.00
Market Cap(Mil.): $36.51
Shares Outstanding(Mil.): 4.41
Dividend: 0.70
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Altus Capital Partners Commences Tender Offer for All Outstanding Shares of MGC Diagnostics Corp

* ‍ALTUS CAPITAL PARTNERS - AC BREATHE MERGER SUB INC COMMENCED PREVIOUSLY-ANNOUNCED TENDER OFFER FOR ALL SHARES OF MGC DIAGNOSTICS CORP AT $11.03/SHARE​ Source text for Eikon: Further company coverage:

29 Nov 2017

BRIEF-MGC Diagnostics Agrees To Be Acquired By Altus Capital Partners

* MGC DIAGNOSTICS CORPORATION AGREES TO BE ACQUIRED BY ALTUS CAPITAL PARTNERS

27 Nov 2017

BRIEF-MGC Diagnostics Corp reports Q3 earnings per share $0.17

* MGC diagnostics corporation reports fiscal 2017 third quarter results

06 Sep 2017

BRIEF-MGC Diagnostics appoints Larry R. Degen as interim CFO

* Says on Aug 30, board of co appointed Larry R. Degen as the company’s interim Chief Financial Officer‍​

01 Sep 2017

Competitors

  Price Chg
Becton Dickinson and Co (BDX.N) $221.46 +2.69

Earnings vs. Estimates